Bahama, NC, United States of America

Daryl W Hochman

USPTO Granted Patents = 19 

Average Co-Inventor Count = 1.3

ph-index = 16

Forward Citations = 1,119(Granted Patents)


Location History:

  • Edmonds, WA (US) (1995 - 2000)
  • Seattle, WA (US) (1997 - 2004)
  • Bahama, NC (US) (2003 - 2017)

Company Filing History:


Years Active: 1995-2017

Loading Chart...
19 patents (USPTO):

Title: Unveiling the Innovations of Daryl W Hochman: Pioneering Inventor in Neuropsychiatric Disorders Treatment.

Introduction: Daryl W Hochman, a renowned inventor hailing from Bahama, NC (US), has made significant contributions to the field of pharmaceuticals and neuropsychiatric disorder treatment. With an impressive portfolio of 19 patents, his cutting-edge inventions have revolutionized the healthcare industry.

Latest Patents: Among his latest patents is the groundbreaking work on bumetanide analogs and compositions for treating a wide array of conditions involving the NaKCl co-transporter or GABA receptor. These analogs hold promise in the treatment of various disorders such as Alzheimer's Disease, epilepsy, schizophrenia, and Parkinson's disease, among others. Additionally, his work on treating neuropathic pain and neuropsychiatric disorders through innovative methods and compositions showcases his commitment to advancing healthcare solutions.

Career Highlights: Daryl W Hochman has left a lasting imprint through his roles at Cytoscan Sciences LLC and the University of Washington. His expertise and dedication have led to the development of novel therapies that have the potential to improve the lives of countless individuals worldwide.

Collaborations: Throughout his illustrious career, Daryl W Hochman has collaborated with esteemed professionals such as Michael M Haglund and John Joseph Partridge. Their joint efforts have propelled the field of neuropsychiatric disorder treatment forward, fostering innovation and excellence.

Conclusion: In conclusion, Daryl W Hochman stands as a trailblazing inventor whose inventive spirit and unwavering commitment to advancing healthcare have set him apart in the industry. His pioneering work continues to shape the landscape of pharmaceuticals and neuropsychiatric disorder treatment, offering hope and healing to those in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…